Members of the CARE Gastroenterology Faculty recently attended the DDW 2017 conference held in Chicago, IL (May 6-9, 2017). At this conference, the 9th annual CARE at DDW education meeting was held. Attendees included academic and community specialists, and residents. This meeting brought together a pan-Canadian Faculty of KOLs to showcase cutting edge content in gastroenterology from DDW. Common themes that the CARE Gastroenterology
faculty focused on include:
- Optimization of current therapy
- Innovation that comes with research and new therapy
- Access to treatment
- The potential impact of technology - both from a specialist and patient perspective
The CARE Perspectives Conference Report from DDW 2017 summarizes the presentations of the participating faculty. The content that follows is written in the language in which it was presented and as applicable includes abstracts identified from DDW 2017. Perspectives are provided by the CARE Gastroenterology Faculty.
For patients with inflammatory bowel disease (IBD), there are several currently available therapies that have helped to improve patient outcomes over the last few years. Emerging, innovative treatments are improving ways of managing patients with IBD and will provide us with more choice and greater treatment flexibility. The CARE Faculty is interested in the views of Canadian gastroenterologists with regards to the impact of new agents in Canada and access to these therapies. We thank you in advance for your valuable feedback! The results from this needs assessment will be shared in future CARE publications.
News from DDW 2017:
DDW 2017. Mo1652. IMPACT OF PROINFLAMMATORY CYTOKINES AND MESALAMINE ON THE EXPRESSION OF THE TIGHT JUNCTION PROTEIN CLAUDIN-1 IN INTESTINAL EPITHELIAL CELLS
DDW 2017. 718. SUPERIOR ENDOSCOPIC AND DEEP REMISSION OUTCOMES IN ADULTS WITH MODERATE TO SEVERE CROHN'S DISEASE MANAGED WITH TREAT TO TARGET APPROACH VERSUS CLINICAL SYMPTOMS: DATA FROM CALM
DDW 2017. 263. INTESTINAL, NON-INTESTINAL, AND EXTRA-DIGESTIVE RESPONSE TO LINACLOTIDE IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION: RESULTS AT WEEK 4 PREDICT SUSTAINED RESPONSE
DDW 2017. Tu1612. IRRITABLE BOWEL SYNDROME PATIENT EXPERIENCE IN CANADA
DDW 2017. 971: AGE OF HELICOBACTER PYLORI ERADICATION AND SUBSEQUENT RISK OF GASTRIC CANCER DEVELOPMENT: A POPULATION-BASED STUDY
DDW 2017. 616. LONG-TERM SAFETY OF ADALIMUMAB IN PATIENTS WITH CROHN'S DISEASE: FINAL DATA FROM PYRAMID REGISTRY